David R Owens, Geremia B Bolli. Diabetes Obes Metab 2020
Times Cited: 31
Times Cited: 31
Times Cited
Times Co-cited
Similarity
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
45
BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.
Tim Heise, Grégory Meiffren, Bertrand Alluis, Cyril Seroussi, Aymeric Ranson, Jorge Arrubla, José Correia, Martin Gaudier, Olivier Soula, Rémi Soula,[...]. Diabetes Obes Metab 2019
Tim Heise, Grégory Meiffren, Bertrand Alluis, Cyril Seroussi, Aymeric Ranson, Jorge Arrubla, José Correia, Martin Gaudier, Olivier Soula, Rémi Soula,[...]. Diabetes Obes Metab 2019
50
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
Julio Rosenstock, Harpreet S Bajaj, Andrej Janež, Robert Silver, Kamilla Begtrup, Melissa V Hansen, Ting Jia, Ronald Goldenberg. N Engl J Med 2020
Julio Rosenstock, Harpreet S Bajaj, Andrej Janež, Robert Silver, Kamilla Begtrup, Melissa V Hansen, Ting Jia, Ronald Goldenberg. N Engl J Med 2020
35
A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5).
David C Klonoff, Mark L Evans, Wendy Lane, Hans-Peter Kempe, Eric Renard, J Hans DeVries, Tina Graungaard, Agon Hyseni, Theis Gondolf, Tadej Battelino. Diabetes Obes Metab 2019
David C Klonoff, Mark L Evans, Wendy Lane, Hans-Peter Kempe, Eric Renard, J Hans DeVries, Tina Graungaard, Agon Hyseni, Theis Gondolf, Tadej Battelino. Diabetes Obes Metab 2019
29
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1).
David Russell-Jones, Bruce W Bode, Christophe De Block, Edward Franek, Simon R Heller, Chantal Mathieu, Athena Philis-Tsimikas, Ludger Rose, Vincent C Woo, Anne Birk Østerskov,[...]. Diabetes Care 2017
David Russell-Jones, Bruce W Bode, Christophe De Block, Edward Franek, Simon R Heller, Chantal Mathieu, Athena Philis-Tsimikas, Ludger Rose, Vincent C Woo, Anne Birk Østerskov,[...]. Diabetes Care 2017
29
Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide.
Jonas Kildegaard, Stephen T Buckley, Rasmus H Nielsen, Gro K Povlsen, Torben Seested, Ulla Ribel, Helle B Olsen, Svend Ludvigsen, Claus B Jeppesen, Hanne H F Refsgaard,[...]. Pharm Res 2019
Jonas Kildegaard, Stephen T Buckley, Rasmus H Nielsen, Gro K Povlsen, Torben Seested, Ulla Ribel, Helle B Olsen, Svend Ludvigsen, Claus B Jeppesen, Hanne H F Refsgaard,[...]. Pharm Res 2019
25
Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial.
Chantal Mathieu, Bruce W Bode, Edward Franek, Athena Philis-Tsimikas, Ludger Rose, Tina Graungaard, Anne Birk Østerskov, David Russell-Jones. Diabetes Obes Metab 2018
Chantal Mathieu, Bruce W Bode, Edward Franek, Athena Philis-Tsimikas, Ludger Rose, Tina Graungaard, Anne Birk Østerskov, David Russell-Jones. Diabetes Obes Metab 2018
25
Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences.
Hanne Haahr, Tim Heise. Clin Pharmacokinet 2020
Hanne Haahr, Tim Heise. Clin Pharmacokinet 2020
50
The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences.
P D Home. Diabetes Obes Metab 2012
P D Home. Diabetes Obes Metab 2012
25
Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.
Tim Heise, Helle Linnebjerg, David Coutant, Elizabeth LaBell, Eric Zijlstra, Christoph Kapitza, Juliana Bue-Valleskey, Qianyi Zhang, Mary Anne Dellva, Jennifer Leohr. Diabetes Obes Metab 2020
Tim Heise, Helle Linnebjerg, David Coutant, Elizabeth LaBell, Eric Zijlstra, Christoph Kapitza, Juliana Bue-Valleskey, Qianyi Zhang, Mary Anne Dellva, Jennifer Leohr. Diabetes Obes Metab 2020
30
Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study.
Leslie Klaff, Dachuang Cao, Mary Anne Dellva, Janet Tobian, Junnosuke Miura, Dominik Dahl, Jean Lucas, Juliana Bue-Valleskey. Diabetes Obes Metab 2020
Leslie Klaff, Dachuang Cao, Mary Anne Dellva, Janet Tobian, Junnosuke Miura, Dominik Dahl, Jean Lucas, Juliana Bue-Valleskey. Diabetes Obes Metab 2020
25
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
22
PEGylated insulin Lispro, (LY2605541)--a new basal insulin analogue.
T M Caparrotta, M Evans. Diabetes Obes Metab 2014
T M Caparrotta, M Evans. Diabetes Obes Metab 2014
22
Insulin analogues in type 1 diabetes mellitus: getting better all the time.
Chantal Mathieu, Pieter Gillard, Katrien Benhalima. Nat Rev Endocrinol 2017
Chantal Mathieu, Pieter Gillard, Katrien Benhalima. Nat Rev Endocrinol 2017
19
Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian Perspective.
Peter Senior, Irene Hramiak. Can J Diabetes 2019
Peter Senior, Irene Hramiak. Can J Diabetes 2019
33
Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D.
Thomas Blevins, Qianyi Zhang, Juan P Frias, Hideaki Jinnouchi, Annette M Chang. Diabetes Care 2020
Thomas Blevins, Qianyi Zhang, Juan P Frias, Hideaki Jinnouchi, Annette M Chang. Diabetes Care 2020
20
Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.
Ib Jonassen, Svend Havelund, Thomas Hoeg-Jensen, Dorte Bjerre Steensgaard, Per-Olof Wahlund, Ulla Ribel. Pharm Res 2012
Ib Jonassen, Svend Havelund, Thomas Hoeg-Jensen, Dorte Bjerre Steensgaard, Per-Olof Wahlund, Ulla Ribel. Pharm Res 2012
19
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial.
Helle Linnebjerg, Qianyi Zhang, Elizabeth LaBell, Mary Anne Dellva, David E Coutant, Ulrike Hövelmann, Leona Plum-Mörschel, Theresa Herbrand, Jennifer Leohr. Clin Pharmacokinet 2020
Helle Linnebjerg, Qianyi Zhang, Elizabeth LaBell, Mary Anne Dellva, David E Coutant, Ulrike Hövelmann, Leona Plum-Mörschel, Theresa Herbrand, Jennifer Leohr. Clin Pharmacokinet 2020
24
A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Ahmad Haidar, Michael A Tsoukas, Sarah Bernier-Twardy, Jean-Francois Yale, Joanna Rutkowski, Anne Bossy, Evelyne Pytka, Anas El Fathi, Natalia Strauss, Laurent Legault. Diabetes Care 2020
Ahmad Haidar, Michael A Tsoukas, Sarah Bernier-Twardy, Jean-Francois Yale, Joanna Rutkowski, Anne Bossy, Evelyne Pytka, Anas El Fathi, Natalia Strauss, Laurent Legault. Diabetes Care 2020
19
19
Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial.
Keith Bowering, Christopher Case, John Harvey, Michael Reeves, Michael Sampson, Robert Strzinek, Ditte-Marie Bretler, Rikke Beck Bang, Bruce W Bode. Diabetes Care 2017
Keith Bowering, Christopher Case, John Harvey, Michael Reeves, Michael Sampson, Robert Strzinek, Ditte-Marie Bretler, Rikke Beck Bang, Bruce W Bode. Diabetes Care 2017
16
Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes.
Eric Zijlstra, Marek Demissie, Tina Graungaard, Tim Heise, Leszek Nosek, Bruce Bode. J Diabetes Sci Technol 2018
Eric Zijlstra, Marek Demissie, Tina Graungaard, Tim Heise, Leszek Nosek, Bruce Bode. J Diabetes Sci Technol 2018
18
Insulin analogues and their potential in the management of diabetes mellitus.
G B Bolli, R D Di Marchi, G D Park, S Pramming, V A Koivisto. Diabetologia 1999
G B Bolli, R D Di Marchi, G D Park, S Pramming, V A Koivisto. Diabetologia 1999
16
Use of fast-acting insulin aspart in insulin pump therapy in clinical practice.
Mark Evans, Antonio Ceriello, Thomas Danne, Christophe De Block, J Hans DeVries, Marcus Lind, Chantal Mathieu, Kirsten Nørgaard, Eric Renard, Emma G Wilmot. Diabetes Obes Metab 2019
Mark Evans, Antonio Ceriello, Thomas Danne, Christophe De Block, J Hans DeVries, Marcus Lind, Chantal Mathieu, Kirsten Nørgaard, Eric Renard, Emma G Wilmot. Diabetes Obes Metab 2019
23
A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes.
Tim Heise, Thomas R Pieber, Thomas Danne, Lars Erichsen, Hanne Haahr. Clin Pharmacokinet 2017
Tim Heise, Thomas R Pieber, Thomas Danne, Lars Erichsen, Hanne Haahr. Clin Pharmacokinet 2017
16
Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetes.
Grit Andersen, Grégory Meiffren, Daniela Lamers, J Hans DeVries, Aymeric Ranson, Cyril Seroussi, Bertrand Alluis, Martin Gaudier, Olivier Soula, Tim Heise. Diabetes Obes Metab 2018
Grit Andersen, Grégory Meiffren, Daniela Lamers, J Hans DeVries, Aymeric Ranson, Cyril Seroussi, Bertrand Alluis, Martin Gaudier, Olivier Soula, Tim Heise. Diabetes Obes Metab 2018
20
Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial.
John B Buse, Anders L Carlson, Mitsuhisa Komatsu, Ofri Mosenzon, Ludger Rose, Bo Liang, Kristine Buchholtz, Hiroshi Horio, Takashi Kadowaki. Diabetes Obes Metab 2018
John B Buse, Anders L Carlson, Mitsuhisa Komatsu, Ofri Mosenzon, Ludger Rose, Bo Liang, Kristine Buchholtz, Hiroshi Horio, Takashi Kadowaki. Diabetes Obes Metab 2018
17
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.
Matthew C Riddle, Julio Rosenstock, John Gerich. Diabetes Care 2003
Matthew C Riddle, Julio Rosenstock, John Gerich. Diabetes Care 2003
16
An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients.
Joseph L Mann, Caitlin L Maikawa, Anton A A Smith, Abigail K Grosskopf, Sam W Baker, Gillie A Roth, Catherine M Meis, Emily C Gale, Celine S Liong, Santiago Correa,[...]. Sci Transl Med 2020
Joseph L Mann, Caitlin L Maikawa, Anton A A Smith, Abigail K Grosskopf, Sam W Baker, Gillie A Roth, Catherine M Meis, Emily C Gale, Celine S Liong, Santiago Correa,[...]. Sci Transl Med 2020
27
LAPS Insulin115: A novel ultra-long-acting basal insulin with a unique action profile.
Nina Wronkowitz, Thorsten Hartmann, Sven Wolfgang Görgens, Daniela Dietze-Schroeder, Ira Indrakusuma, In Young Choi, Sung Hee Park, Young-Mi Lee, Se Chang Kwon, Yeonjoo Kang,[...]. Diabetes Obes Metab 2017
Nina Wronkowitz, Thorsten Hartmann, Sven Wolfgang Görgens, Daniela Dietze-Schroeder, Ira Indrakusuma, In Young Choi, Sung Hee Park, Young-Mi Lee, Se Chang Kwon, Yeonjoo Kang,[...]. Diabetes Obes Metab 2017
26
How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes.
Araceli Muñoz-Garach, María Molina-Vega, Francisco J Tinahones. Diabetes Ther 2017
Araceli Muñoz-Garach, María Molina-Vega, Francisco J Tinahones. Diabetes Ther 2017
27
Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial.
Inge B Halberg, Karsten Lyby, Karsten Wassermann, Tim Heise, Eric Zijlstra, Leona Plum-Mörschel. Lancet Diabetes Endocrinol 2019
Inge B Halberg, Karsten Lyby, Karsten Wassermann, Tim Heise, Eric Zijlstra, Leona Plum-Mörschel. Lancet Diabetes Endocrinol 2019
16
Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.
Tim Heise, Leszek Nosek, Birgitte Biilmann Rønn, Lars Endahl, Lutz Heinemann, Christoph Kapitza, Eberhard Draeger. Diabetes 2004
Tim Heise, Leszek Nosek, Birgitte Biilmann Rønn, Lars Endahl, Lutz Heinemann, Christoph Kapitza, Eberhard Draeger. Diabetes 2004
16
Insulin Access and Affordability Working Group: Conclusions and Recommendations.
William T Cefalu, Daniel E Dawes, Gina Gavlak, Dana Goldman, William H Herman, Karen Van Nuys, Alvin C Powers, Simeon I Taylor, Alan L Yatvin. Diabetes Care 2018
William T Cefalu, Daniel E Dawes, Gina Gavlak, Dana Goldman, William H Herman, Karen Van Nuys, Alvin C Powers, Simeon I Taylor, Alan L Yatvin. Diabetes Care 2018
16
Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes.
Tim Heise, Chantal Mathieu. Diabetes Obes Metab 2017
Tim Heise, Chantal Mathieu. Diabetes Obes Metab 2017
16
Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes.
Francesca Porcellati, Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli, Gianluca Curti, Geremia B Bolli, Carmine G Fanelli. Diabetes Care 2019
Francesca Porcellati, Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli, Gianluca Curti, Geremia B Bolli, Carmine G Fanelli. Diabetes Care 2019
22
Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2.
Mark Warren, Bruce Bode, Jang I Cho, Rong Liu, Janet Tobian, Thomas Hardy, Farai Chigutsa, Moshe Phillip, Barry Horowitz, Debra Ignaut. Diabetes Obes Metab 2021
Mark Warren, Bruce Bode, Jang I Cho, Rong Liu, Janet Tobian, Thomas Hardy, Farai Chigutsa, Moshe Phillip, Barry Horowitz, Debra Ignaut. Diabetes Obes Metab 2021
38
New insulin glargine 300 Units · mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units · mL-1.
Reinhard H A Becker, Raphael Dahmen, Karin Bergmann, Anne Lehmann, Thomas Jax, Tim Heise. Diabetes Care 2015
Reinhard H A Becker, Raphael Dahmen, Karin Bergmann, Anne Lehmann, Thomas Jax, Tim Heise. Diabetes Care 2015
16
'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analogues.
Mark A Jarosinski, Balamurugan Dhayalan, Nischay Rege, Deepak Chatterjee, Michael A Weiss. Diabetologia 2021
Mark A Jarosinski, Balamurugan Dhayalan, Nischay Rege, Deepak Chatterjee, Michael A Weiss. Diabetologia 2021
22
Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans.
Thomas B Kjeldsen, František Hubálek, Claudia U Hjørringgaard, Tina M Tagmose, Erica Nishimura, Carsten E Stidsen, Trine Porsgaard, Christian Fledelius, Hanne H F Refsgaard, Sanne Gram-Nielsen,[...]. J Med Chem 2021
Thomas B Kjeldsen, František Hubálek, Claudia U Hjørringgaard, Tina M Tagmose, Erica Nishimura, Carsten E Stidsen, Trine Porsgaard, Christian Fledelius, Hanne H F Refsgaard, Sanne Gram-Nielsen,[...]. J Med Chem 2021
35
Engineering Glucose Responsiveness Into Insulin.
Niels C Kaarsholm, Songnian Lin, Lin Yan, Theresa Kelly, Margaret van Heek, James Mu, Margaret Wu, Ge Dai, Yan Cui, Yonghua Zhu,[...]. Diabetes 2018
Niels C Kaarsholm, Songnian Lin, Lin Yan, Theresa Kelly, Margaret van Heek, James Mu, Margaret Wu, Ge Dai, Yan Cui, Yonghua Zhu,[...]. Diabetes 2018
16
Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?
P D Home. Diabetes Obes Metab 2015
P D Home. Diabetes Obes Metab 2015
12
Adding fast-acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18-week, open-label, phase 3 trial (onset 3).
Helena W Rodbard, Devjit Tripathy, Maricela Vidrio Velázquez, Marek Demissie, Søren C Tamer, Milivoj Piletič. Diabetes Obes Metab 2017
Helena W Rodbard, Devjit Tripathy, Maricela Vidrio Velázquez, Marek Demissie, Søren C Tamer, Milivoj Piletič. Diabetes Obes Metab 2017
12
Optimal prandial timing of bolus insulin in diabetes management: a review.
D Slattery, S A Amiel, P Choudhary. Diabet Med 2018
D Slattery, S A Amiel, P Choudhary. Diabet Med 2018
12
A review of a family of ultra-rapid-acting insulins: formulation development.
Alan Krasner, Roderike Pohl, Patrick Simms, Philip Pichotta, Robert Hauser, Errol De Souza. J Diabetes Sci Technol 2012
Alan Krasner, Roderike Pohl, Patrick Simms, Philip Pichotta, Robert Hauser, Errol De Souza. J Diabetes Sci Technol 2012
14
Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.
Klemen Dovc, Claudia Piona, Gül Yeşiltepe Mutlu, Natasa Bratina, Barbara Jenko Bizjan, Dusanka Lepej, Revital Nimri, Eran Atlas, Ido Muller, Olga Kordonouri,[...]. Diabetes Care 2020
Klemen Dovc, Claudia Piona, Gül Yeşiltepe Mutlu, Natasa Bratina, Barbara Jenko Bizjan, Dusanka Lepej, Revital Nimri, Eran Atlas, Ido Muller, Olga Kordonouri,[...]. Diabetes Care 2020
12
Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial.
Bruce W Bode, Violeta Iotova, Margarita Kovarenko, Lori M Laffel, Paturi V Rao, Srikanth Deenadayalan, Magnus Ekelund, Steffen Falgreen Larsen, Thomas Danne. Diabetes Care 2019
Bruce W Bode, Violeta Iotova, Margarita Kovarenko, Lori M Laffel, Paturi V Rao, Srikanth Deenadayalan, Magnus Ekelund, Steffen Falgreen Larsen, Thomas Danne. Diabetes Care 2019
22
Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart.
T Heise, U Hövelmann, L Brøndsted, C L Adrian, L Nosek, H Haahr. Diabetes Obes Metab 2015
T Heise, U Hövelmann, L Brøndsted, C L Adrian, L Nosek, H Haahr. Diabetes Obes Metab 2015
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.